These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
384 related items for PubMed ID: 21372220
1. Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors. Breinig M, Mayer P, Harjung A, Goeppert B, Malz M, Penzel R, Neumann O, Hartmann A, Dienemann H, Giaccone G, Schirmacher P, Kern MA, Chiosis G, Rieker RJ. Clin Cancer Res; 2011 Apr 15; 17(8):2237-49. PubMed ID: 21372220 [Abstract] [Full Text] [Related]
2. Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors. Gloesenkamp C, Nitzsche B, Lim AR, Normant E, Vosburgh E, Schrader M, Ocker M, Scherübl H, Höpfner M. Int J Oncol; 2012 May 15; 40(5):1659-67. PubMed ID: 22246317 [Abstract] [Full Text] [Related]
3. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. Georgakis GV, Li Y, Rassidakis GZ, Martinez-Valdez H, Medeiros LJ, Younes A. Clin Cancer Res; 2006 Jan 15; 12(2):584-90. PubMed ID: 16428504 [Abstract] [Full Text] [Related]
4. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo. Schwock J, Pham NA, Cao MP, Hedley DW. Cancer Chemother Pharmacol; 2008 Apr 15; 61(4):669-81. PubMed ID: 17579866 [Abstract] [Full Text] [Related]
5. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines. Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F. Invest Ophthalmol Vis Sci; 2008 Jun 15; 49(6):2348-56. PubMed ID: 18281615 [Abstract] [Full Text] [Related]
6. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma. Desbois-Mouthon C, Baron A, Blivet-Van Eggelpoël MJ, Fartoux L, Venot C, Bladt F, Housset C, Rosmorduc O. Clin Cancer Res; 2009 Sep 01; 15(17):5445-56. PubMed ID: 19706799 [Abstract] [Full Text] [Related]
12. Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells. Qin B, Ariyama H, Baba E, Tanaka R, Kusaba H, Harada M, Nakano S. Cancer Chemother Pharmacol; 2006 Nov 01; 58(5):577-84. PubMed ID: 16532343 [Abstract] [Full Text] [Related]
13. An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma. Lin H, Kolosenko I, Björklund AC, Protsyuk D, Österborg A, Grandér D, Tamm KP. Exp Cell Res; 2013 Mar 10; 319(5):600-11. PubMed ID: 23246572 [Abstract] [Full Text] [Related]